Your assumptions and views are all messed up. Medafor presently has sufficient cash flow to both grow and litigate. I admit it would be nice not to have to litigate, but Medafor sales and cash flow are growing nicely. Audited financial statements, no big rush. Why help CRY do any do diligence? CRY's tissue business possibly being challenged! Bioglue market possibly being challenged! Hemostase market probably not doing that well for CRY, because they seem focused on selling tissue and Bioglue, not Hemostase.
If SGA wants Medfor, then offer a 1:1 share exchange and make a game out of it. Otherwise, Medafor will just take the contract minimums and burn the clock. It is great for Medafor shareholders if GS and GT manage the company for another 4 years.
for Medafor? What multiple on earnings is that? But please don't answer, because that would make you look very very foolish and it might be more pathetic than funny.
Very competitive market out there that your sub-micro revenue company is trying to survive in. So yes, medafor needs more capital. Believe it or not--but you have those "financial statements" to rely on to base your investments, don't you.
What is really funny is that you vowed to fight! fight! the CRY takeover...but you don't know what you are fighting for. I'm guessing you have a relative working at Medafor and that is why you are so goofy.